| Literature DB >> 33781607 |
Corey S Davis1, Derek H Carr2, Melody J Glenn3, Elizabeth A Samuels4.
Abstract
Treatment with buprenorphine significantly reduces both all-cause and overdose mortality among individuals with opioid use disorder. Offering buprenorphine treatment to individuals who experience a nonfatal opioid overdose represents an opportunity to reduce opioid overdose fatalities. Although some emergency departments (EDs) initiate buprenorphine treatment, many individuals who experience an overdose either refuse transport to the ED or are transported to an ED that does not offer buprenorphine. Emergency medical services (EMS) professionals can help address this treatment gap. In this Concepts article, we describe the federal legal landscape that governs the ability of EMS professionals to administer buprenorphine treatment, and discuss state and local regulatory considerations relevant to this promising and emerging practice.Entities:
Mesh：
Substances：
Year: 2021 PMID： 33781607 PMCID： PMC8238848 DOI： 10.1016/j.annemergmed.2021.01.017
Source DB: PubMed Journal: Ann Emerg Med ISSN： 0196-0644 Impact factor: 6.762